CoChat

Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation

Yin, Yi, Huang, Xianming, Lynn, Kristi D., Thorpe, Philip E. · 2013 · Cancer Immunology Research

Published version of a preprint

Cited by 149

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Multiple tumor-derived factors are responsible for the accumulation and expansion of immune-suppressing myeloid-derived suppressor cells (MDSC) and M2-like tumor-associated macrophages (TAM) in tumors. Here, we show that treatment of tumor-bearing mice with docetaxel in combination with the phosphatidylserine-targeting antibody 2aG4 potently suppressed the growth and progression of prostate tumors, depleted M2-like TAMs, and MDSCs, and increased the presence of M1-like TAMs and mature dendritic cells in the tumors. In addition, the antibody markedly altered the cytokine balance in the tumor microenvironment from immunosuppressive to immunostimulatory. In vitro studies confirmed that 2aG4 repolarized TAMs from an M2- to an M1-like phenotype and drove the differentiation of MDSCs into M1-like TAMs and functional dendritic cells. These data suggest that phosphatidylserine is responsible for the expansion of MDSCs and M2-like TAMs in tumors, and that bavituximab, a phosphatidylserine-targeting antibody currently in clinical trials for cancer, could reverse this process and reactivate antitumor immunity. Cancer Immunol Res; 1(4); 256–68. ©2013 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2326-6066.cir-13-0073

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 41

  1. Gabrilovich, 2004, Mechanisms and functional significance of tumour-induced dendritic-cell defects, Nat Rev Immunol, 4, 941, 10.1038/nri1498 · DOI · Paper page
  2. Yang, 2006, CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells, Cancer Res, 66, 6807, 10.1158/0008-5472.CAN-05-3755 · DOI · Paper page
  3. Li, 2009, Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1, J Immunol, 182, 240, 10.4049/jimmunol.182.1.240 · DOI · Paper page
  4. Bronte, 2000, Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells, Blood, 96, 3838, 10.1182/blood.V96.12.3838 · DOI · Paper page
  5. Filipazzi, 2007, Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine, J Clin Oncol, 25, 2546, 10.1200/JCO.2006.08.5829 · DOI · Paper page
  6. Kusmartsev, 2003, Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species, J Leukoc Biol, 74, 186, 10.1189/jlb.0103010 · DOI · Paper page
  7. Kusmartsev, 2005, STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion, J Immunol, 174, 4880, 10.4049/jimmunol.174.8.4880 · DOI · Paper page
  8. Troy, 1998, Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer, J Urol, 160, 214, 10.1016/S0022-5347(01)63093-3 · DOI
  9. Murdoch, 2005, Macrophage migration and gene expression in response to tumor hypoxia, Int J Cancer, 117, 701, 10.1002/ijc.21422 · DOI · Paper page
  10. Kurahara, 2011, Significance of M2-polarized tumor-associated macrophage in pancreatic cancer, J Surg Res, 167, e211, 10.1016/j.jss.2009.05.026 · DOI · Paper page
  11. Yoshikawa, 2012, Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head, Cancer Sci, 103, 2012, 10.1111/j.1349-7006.2012.02411.x · DOI
  12. Ma, 2010, The M1 form of tumor-associated macrophages in non–small cell lung cancer is positively associated with survival time, BMC Cancer, 10, 112, 10.1186/1471-2407-10-112 · DOI · Paper page
  13. Fadok, 1992, Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages, J Immunol, 148, 2207, 10.4049/jimmunol.148.7.2207 · DOI · Paper page
  14. McDonald, 1999, Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells, J Immunol, 163, 6164, 10.4049/jimmunol.163.11.6164 · DOI · Paper page
  15. Balasubramanian, 2003, Aminophospholipid asymmetry: a matter of life and death, Annu Rev Physiol, 65, 701, 10.1146/annurev.physiol.65.092101.142459 · DOI · Paper page
  16. Ran, 2002, Increased exposure of anionic phospholipids on the surface of tumor blood vessels, Cancer Res, 62, 6132
  17. Ran, 2005, Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice, Clin Cancer Res, 11, 1551, 10.1158/1078-0432.CCR-04-1645 · DOI
  18. Taylor, 2011, Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments, Semin Immunopathol, 33, 441, 10.1007/s00281-010-0234-8 · DOI · Paper page
  19. Utsugi, 1991, Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes, Cancer Res, 51, 3062
  20. He, 2007, Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids, Clin Cancer Res, 13, 5211, 10.1158/1078-0432.CCR-07-0793 · DOI
  21. Huang, 2005, A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice, Cancer Res, 65, 4408, 10.1158/0008-5472.CAN-05-0031 · DOI · Paper page
  22. He, 2011, Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells, EMBO Rep, 12, 358, 10.1038/embor.2011.28 · DOI · Paper page
  23. Freeman, 2010, TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity, Immunol Rev, 235, 172, 10.1111/j.0105-2896.2010.00903.x · DOI · Paper page
  24. Park, 2007, BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module, Nature, 450, 430, 10.1038/nature06329 · DOI · Paper page
  25. Park, 2008, Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor, Cell Death Differ, 15, 192, 10.1038/sj.cdd.4402242 · DOI · Paper page
  26. Balasubramanian, 1998, Characterization of phosphatidylserine-dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes, J Biol Chem, 273, 29272, 10.1074/jbc.273.44.29272 · DOI · Paper page
  27. Bondanza, 2004, Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo, J Exp Med, 200, 1157, 10.1084/jem.20040327 · DOI · Paper page
  28. He, 2009, Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma, Clin Cancer Res, 15, 6871, 10.1158/1078-0432.CCR-09-1499 · DOI
  29. Kenis, 2009, Targeting phosphatidylserine in anti-cancer therapy, Curr Pharm Des, 15, 2719, 10.2174/138161209788923903 · doi:10.2174/138161209788923903
  30. Digumarti, 2010, Phase II study of bavituximab plus paclitaxel and carboplatin in untreated locally advanced or metastatic non–small cell lung cancer: interim results, J Clin Oncol, 28, 7589, 10.1200/jco.2010.28.15_suppl.7589 · doi:10.1200/jco.2010.28.15_suppl.7589
  31. Gerber, 2011, Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors, Clin Cancer Res, 17, 6888, 10.1158/1078-0432.CCR-11-1074 · DOI
  32. Jain, 2010, Phase II study of bavituximab plus paclitaxel and carboplatin in locally advanced or metastatic breast cancer: interim results, J Clin Oncol, 28, 1062, 10.1200/jco.2010.28.15_suppl.1062 · DOI
  33. Luster, 2006, Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells, J Biol Chem, 281, 29863, 10.1074/jbc.M605252200 · DOI
  34. Ran, 2002, Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy, Int J Radiat Oncol Biol Phys, 54, 1479, 10.1016/S0360-3016(02)03928-7 · DOI · Paper page
  35. Szajnik, 2010, Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg), PLoS ONE, 5, e11469, 10.1371/journal.pone.0011469 · DOI · Paper page
  36. Yan, 2012, Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo, Cancer Immunol Immunother, 61, 1917, 10.1007/s00262-012-1250-4 · DOI
  37. Lima, 2009, Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner, Cancer Lett, 283, 168, 10.1016/j.canlet.2009.03.041 · DOI · Paper page
  38. Beatty, 2011, CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans, Science, 331, 1612, 10.1126/science.1198443 · DOI · Paper page
  39. Zhou, 2011, Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions, Int Immunopharmacol, 11, 890, 10.1016/j.intimp.2011.01.007 · DOI · Paper page
  40. Chen, 2004, Phosphatidylserine regulates the maturation of human dendritic cells, J Immunol, 173, 2985, 10.4049/jimmunol.173.5.2985 · DOI · Paper page
  41. Simeone, 2012, Immunomodulating antibodies in the treatment of metastatic melanoma: the experience with anti-CTLA-4, anti-CD137, and anti-PD1, J Immunotoxicol, 9, 241, 10.3109/1547691X.2012.678021 · DOI

Cited by

See all 149

Metadata

Authors
Yin, Y., Huang, X., Lynn, K. D., & Thorpe, P. E.
Venue
Cancer Immunology Research
Published
2013-10-01
Volume
1
Issue
4
Pages
256-268
ISSN
  • 2326-6066 (ISSN-L)
  • 2326-6074
OpenAlex
W2164839146
Cited by
149
References
9
FWCI
5.51
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation. https://app.cochat.ai/papers/10.1158/2326-6066.cir-13-0073
The paper
Yin, Y., Huang, X., Lynn, K. D., & Thorpe, P. E. (2013). Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-13-0073

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.